DNAnexus key facts
- Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data.
- It has raised $666.0M across 2 recorded rounds; the latest was Early Stage VC ($15.0M) in Apr 2015.
- Notable investors include GV, SV Angel, Felicis, First Round Capital, Blackstone — 24 tracked in total.
- DNAnexus has filed 3 Form Ds with the SEC since 2009, most recently Apr 2015 ($15.0M sold to 1 investors).
- Status: Privately Held (backing).
Who backs DNAnexus
24+Membership and data by Private Market View
- ·The complete investor list: 24 names
- ·Watch DNAnexus: the Monday email on marks, rounds and moves
DNAnexus funding rounds
2 roundsHow much has DNAnexus raised?
DNAnexus has raised $666 million in total; 2 of its rounds are on record. The largest on record was a $15 million early-stage round in Dec 2013; the most recent was a $15 million early-stage round in Apr 2015.
DNAnexus has filed 3 Form Ds with the SEC since 2009, most recently in Apr 2015 ($15 million sold to 1 investor).
DNAnexus investors
24 investors are on record for DNAnexus, including GV, SV Angel, Felicis and First Round Capital. By type, the record holds 5 venture capital firms and 1 hedge fund. The early-stage round in Apr 2015 drew 1 investor.
About DNAnexus
Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company's platform assists researchers across a spectrum of industries like biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia to accelerate their genomics programs globally, enabling commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, unified system.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2009
- Employees
- 280
- Website
- dnanexus.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
DNAnexus doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.